<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>231778c6-760b-4594-b755-15ea1e37b46a</id>
  <name>COVID Immunomodulatory PICU Order Group</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~231778c6-760b-4594-b755-15ea1e37b46a~NAME~COVID Immunomodulatory PICU Order Group}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Consider if patient greater than 12 years of age, unvaccinated, seronegative, no prior COVID-19 infection OR if patient immunocompromised – casirivimab/imdevimab (REGEN-COV)&lt;/p&gt;&lt;p&gt;- Recommend consultation to Pediatric Infectious Disease.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;-&amp;nbsp;&lt;u&gt;&lt;strong&gt;AHS Formulary&lt;/strong&gt;&lt;/u&gt;&amp;nbsp;(URL:&amp;nbsp;https://ahsweb.ca/HEE/ahs_formulary_casirivimab_imdevimab)&lt;/p&gt;&lt;p&gt;-&amp;nbsp;&lt;u&gt;&lt;strong&gt;Manual: COVID-19 Neutralizing Antibodies &amp;nbsp;Orders&lt;/strong&gt;&lt;/u&gt;&amp;nbsp;(URL:&amp;nbsp;https://manual.connect-care.ca/home/hot-topics/covid-19/covid-19-decision-supports/covid-19-casirivimab-imdevimab-orders)&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Recommend consultation to Pediatric Infectious Disease.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;-&amp;nbsp;&lt;strong&gt;&lt;u&gt;AHS Formulary - tocilizumab&lt;/u&gt;&lt;/strong&gt;&amp;nbsp;(https://ahsweb.ca/HEE/ahs_formulary_tocilizumab)&lt;/p&gt;&lt;p&gt;-&amp;nbsp;&lt;strong&gt;&lt;u&gt;AHS Formualry - baricitinib&lt;/u&gt;&lt;/strong&gt;&amp;nbsp;(https://ahsweb.ca/HEE/ahs_formulary_baricitinib)&lt;/p&gt;&lt;p&gt;-&amp;nbsp;&lt;strong&gt;&lt;u&gt;Manual: COVID-19&lt;/u&gt;&lt;/strong&gt;&lt;strong&gt;&lt;u&gt;&amp;nbsp;&lt;/u&gt;&lt;/strong&gt;&lt;strong&gt;&lt;u&gt;Immunomodulator&lt;/u&gt;&lt;/strong&gt;&lt;strong&gt;&lt;u&gt;&amp;nbsp;&lt;/u&gt;&lt;/strong&gt;&lt;strong&gt;&lt;u&gt;Orders&lt;/u&gt;&lt;/strong&gt;&amp;nbsp;(URL:&amp;nbsp;https://manual.connect-care.ca/home/hot-topics/covid-19/covid-19-decision-supports/covid-19-tocilizumab-orders)&amp;nbsp;&lt;/p&gt;&lt;p&gt;-&amp;nbsp;&lt;strong&gt;&lt;u&gt;Guidance:&lt;/u&gt;&lt;/strong&gt;&lt;strong&gt;&lt;u&gt;&amp;nbsp;&lt;/u&gt;&lt;/strong&gt;&lt;strong&gt;&lt;u&gt;Current Guidance for the Management of Adult Hospitalized Patients with COVID-19&lt;/u&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;(URL:https://ahsweb.ca/HEE/Management_of_Adult_Hospitalized_Patients_with_COVID_19)&lt;/p&gt;&lt;p&gt;-&amp;nbsp;&lt;strong&gt;&lt;u&gt;Guidance: Therapeutic Management of Adult Patients with COVID-19 &lt;/u&gt;&lt;/strong&gt;(URL:&amp;nbsp;https://ahsweb.ca/HEE/Antimicrobial_Immunomodulatory_Therapy_Adult_Patients_COVID_19)&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Immunomodulatory">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Consider if admission less than 7 days, significant respiratory failure requiring high-flow nasal cannula, ventilation (invasive or non-invasive) less than 24 hours previous - tocilizumab OR baricitinib">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="02090773-b839-4322-9faf-55959041c9c7" concept_name="PHARM tocilizumab injection Order" max="1" path="/items" name="tocilizumab injection; *** mg, intravenous, once"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="97d91fca-9095-472a-84f5-10f5d7dd77b1" concept_name="PHARM Baricitinib tablet Order" max="1" path="/items" name="Baricitinib tablet; 4 mg, oral, daily, for 14 days"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="baricitinib - Renal Dysfunction Dosing">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="97d91fca-9095-472a-84f5-10f5d7dd77b1" concept_name="PHARM Baricitinib tablet Order" max="1" path="/items" name="Baricitinib tablet; 2 mg, oral, daily, for 14 days"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="97d91fca-9095-472a-84f5-10f5d7dd77b1" concept_name="PHARM Baricitinib tablet Order" max="1" path="/items" name="Baricitinib tablet; 2 mg, oral, every 2 days, for 14 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
</template>